Latest news

NEW ANALYSIS FINDS ACCELERATED APPROVAL DRUGS DO NOT DRIVE MEDICAID SPENDING
Findings Published in Health Affairs Forefront   Precedent-setting policies to restrict access to accelerated approval drugs do not reduce health care spending but rather harm America’s most vulnerable patients   June 3, 2022 (WASHINGTON, D.C.) The Partnership to Fight
Press release
Jun 3,2022
Compromising Patient Access Is Not a Path Forward for Alzheimer’s Disease
CMS decision harms current and future treatment options for Alzheimer's and other chronic disease populations   April 8, 2022 (Washington, D.C.) The Partnership to Fight Chronic Disease (PFCD) released the following statement from Chair Ken Thorpe regarding the Centers for Medicare and
Press release
Apr 8,2022
Never Undermine Scientific Discovery — Especially Now
March 01, 2022 Real Clear Policy  By Kenneth E. Thorpe    While the pandemic is by no means over, Covid-19 isn't the only threat to public health we face. In fact, it might not even be our most serious challenge.   Despite the tragic loss of more than 2,000 American
OP-ED
Mar 1,2022
Oregon's Medicaid waiver hurts chronic disease patients
  By Kenneth E. Thorpe February 3, 2022   More than half of Oregon's population -- nearly 2.3 million people -- is living with at least one chronic disease.[1][2] A disproportionate share rely on Medicaid to provide them the medications they need, and are beneficiaries because of
OP-ED
Feb 3,2022
Driving Health Care Reforms Now Will Impact Future Generations, Getting It Right Is Critical For Millions of Families Managing Chronic Conditions
  WASHINGTON (December 7, 2021) -- Today, the Partnership to Fight Chronic Disease (PFCD) released the following statement following President Biden’s remarks on the costs of prescription drugs.   “Especially as Americans are still very much navigating a path forward from
Press release
Dec 7,2021
Any Drug Pricing Compromise Must Lower Costs and Preserve Access to Innovative Therapies. Congress Can, and Should, Do Both.
  WASHINGTON, D.C. (November 3, 2021) Today, the Partnership to Fight Chronic Disease (PFCD) released the following statement on the drug pricing plan that Congress is considering.   “While we wait to see the details of this plan, Senate negotiators have apparently taken some
Press release
Nov 3,2021
Reinforce The Pandemic's Partnerships For Innovation
By Kenneth Thorpe  10/24/21 AT 6:30 AM   Beating Covid-19 has certainly taken longer than most of us were hoping, but we've turned the corner, and it's never too early to begin the critical exercise of assessing "lessons learned."   Clearly, in numerous
OP-ED
Oct 25,2021
FDA’s Accelerated Approval Pathway: Separating Fact From Fiction
BY PAT FURLONG , ANNIE KENNEDY & KEN THORPE October 20, 2021 at 5:00 am ET   Today, you can go from hero to villain instantaneously. The Food and Drug Administration was rightfully applauded for efficiently reviewing COVID-19
OP-ED
Oct 20,2021
Partnership to Fight Chronic Disease Advocates for Solutions Not Slogans for the Millions of Americans Living with and Impacted by Chronic Disease
PFCD’s ongoing advertisements elevate patient voices on oversights of current legislative proposals on truly lowering health care costs   WASHINGTON, D.C. (October 18, 2021) – The Partnership to Fight Chronic Disease (PFCD) today announced a new round of television and digital
Press release
Oct 19,2021
Another Voice: Intellectual property rules enable vaccine innovation
Intellectual property protections help keep the world safe. Getting a drug successfully to market can cost billions of dollars and take several years of scientific toil. Blood, sweat, tears – and money. Fewer than one in 10 products that enter clinical trials are ever greenlit by the FDA. If
OP-ED
Oct 12,2021

Pages